Cargando…
Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies
Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277618/ https://www.ncbi.nlm.nih.gov/pubmed/35766018 http://dx.doi.org/10.1039/d1sm01111a |
_version_ | 1784746022986055680 |
---|---|
author | Baxani, D. K. Jamieson, W. D. Barrow, D. A. Castell, O. K. |
author_facet | Baxani, D. K. Jamieson, W. D. Barrow, D. A. Castell, O. K. |
author_sort | Baxani, D. K. |
collection | PubMed |
description | Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bilayer experimental conditions. Here, droplet bilayers encapsulated within a hydrogel shell are output individually into multi-well plates for simple, arrayed quantitative measurements. The afforded experimental throughput is used to conduct a 2D concentration screen characterising the synergistic pore-forming peptides Magainin2 and PGLa. Maximal enhanced activity is revealed at equimolar peptide concentrations via a membrane dye leakage assay, a finding consistent with models proposed from NMR data. The versatility of the platform is demonstrated by performing in situ electrophysiology, revealing low conductance pore activity (∼15 to 20 pA with 4.5 pA sub-states). In conclusion, this array platform addresses the aforementioned challenges and provides new and flexible opportunities for high-throughput membrane studies. Furthermore, the ability to engineer droplet networks within each construct paves the way for “lab-in-a-capsule” approaches accommodating multiple assays per construct and allowing for communicative reaction pathways. |
format | Online Article Text |
id | pubmed-9277618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-92776182022-08-01 Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies Baxani, D. K. Jamieson, W. D. Barrow, D. A. Castell, O. K. Soft Matter Chemistry Whilst it is highly desirable to produce artificial lipid bilayer arrays allowing for systematic high-content screening of membrane conditions, it remains a challenge due to the combined requirements of scaled membrane production, simple measurement access, and independent control over individual bilayer experimental conditions. Here, droplet bilayers encapsulated within a hydrogel shell are output individually into multi-well plates for simple, arrayed quantitative measurements. The afforded experimental throughput is used to conduct a 2D concentration screen characterising the synergistic pore-forming peptides Magainin2 and PGLa. Maximal enhanced activity is revealed at equimolar peptide concentrations via a membrane dye leakage assay, a finding consistent with models proposed from NMR data. The versatility of the platform is demonstrated by performing in situ electrophysiology, revealing low conductance pore activity (∼15 to 20 pA with 4.5 pA sub-states). In conclusion, this array platform addresses the aforementioned challenges and provides new and flexible opportunities for high-throughput membrane studies. Furthermore, the ability to engineer droplet networks within each construct paves the way for “lab-in-a-capsule” approaches accommodating multiple assays per construct and allowing for communicative reaction pathways. The Royal Society of Chemistry 2022-06-17 /pmc/articles/PMC9277618/ /pubmed/35766018 http://dx.doi.org/10.1039/d1sm01111a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Baxani, D. K. Jamieson, W. D. Barrow, D. A. Castell, O. K. Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title | Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title_full | Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title_fullStr | Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title_full_unstemmed | Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title_short | Encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
title_sort | encapsulated droplet interface bilayers as a platform for high-throughput membrane studies |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277618/ https://www.ncbi.nlm.nih.gov/pubmed/35766018 http://dx.doi.org/10.1039/d1sm01111a |
work_keys_str_mv | AT baxanidk encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies AT jamiesonwd encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies AT barrowda encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies AT castellok encapsulateddropletinterfacebilayersasaplatformforhighthroughputmembranestudies |